Loading...
Combination Chemotherapeutic Dry Powder Aerosols via Controlled Nanoparticle Agglomeration
El-Gendy, Nashwa Berkland, Cory J.
El-Gendy, Nashwa
Berkland, Cory J.
Citations
Altmetric:
Abstract
Purpose
To develop an aerosol system for efficient local lung delivery of chemotherapeutics where nanotechnology holds tremendous potential for developing more valuable cancer therapies. Concurrently, aerosolized chemotherapy is generating interest as a means to treat certain types of lung cancer more effectively with less systemic exposure to the compound.
Methods
Nanoparticles of the potent anticancer drug, paclitaxel, were controllably assembled to form low density microparticles directly after preparation of the nanoparticle suspension. The amino acid, L-leucine, was used as a colloid destabilizer to drive the assembly of paclitaxel nanoparticles. A combination chemotherapy aerosol was formed by assembling the paclitaxel nanoparticles in the presence of cisplatin in solution.
Results
Freeze-dried powders of the combination chemotherapy possessed desirable aerodynamic properties for inhalation. In addition, the dissolution rates of dried nanoparticle agglomerate formulations (~60% to 66% after 8 h) were significantly faster than that of micronized paclitaxel powder as received (~18% after 8 h). Interestingly, the presence of the water soluble cisplatin accelerated the dissolution of paclitaxel.
Conclusions
Nanoparticle agglomerates of paclitaxel alone or in combination with cisplatin may serve as effective chemotherapeutic dry powder aerosols to enable regional treatment of certain lung cancers.
Description
The original publication is available at www.springerlink.com
Date
2009-05-05
Journal Title
Journal ISSN
Volume Title
Publisher
American Association of Pharmaceutical Scientists
Collections
Files
Loading...
berkland_combination.pdf
Adobe PDF, 483.1 KB
Research Projects
Organizational Units
Journal Issue
Keywords
Cisplatin, Combination chemotherapy, Dry powder, Nanoparticle agglomerates, Paclitaxel
Citation
El-Gendy, Nashwa, and Cory Berkland. “Combination Chemotherapeutic Dry Powder Aerosols via Controlled Nanoparticle Agglomeration.” Pharmaceutical research 26.7 (2009): 1752–1763.